Literature DB >> 26664327

Diagnostic Approach to Hereditary Colorectal Cancer Syndromes.

Matthew F Kalady1, Brandie Heald2.   

Abstract

Approximately 5 to 10% of colorectal cancers develop within a known hereditary syndrome. Specific underlying genetic mutations drive the clinical phenotype and it is imperative to determine the genetic etiology to provide meaningful surveillance and intervention. Recognizing potential patients and families with a hereditary predisposition is the first step in management. Syndromes can be categorized according to polyp burden as polyposis or nonpolyposis. Clinical assessment should start with a personal and family medical history, physical examination, and evaluation for the presence and type of colorectal polyps or cancers. Key information is gained from these simple steps and should guide the specific genetic analysis for diagnosis. Genetic counseling is a critical component to any hereditary colorectal cancer program and should be conducted before genetic testing to provide education about the implications of test results. This review focuses on the thought process that drives initial clinical evaluation and guides genetic testing for patients with suspected hereditary colorectal cancer syndromes.

Entities:  

Keywords:  Lynch syndrome; MYH-associated polyposis; familial adenomatous polyposis; genetic testing; hereditary colorectal cancer syndromes; hereditary nonpolyposis colorectal cancer

Year:  2015        PMID: 26664327      PMCID: PMC4654621          DOI: 10.1055/s-0035-1564432

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  60 in total

1.  MYH-associated polyposis: adenomas and hyperplastic polyps, partners in crime?

Authors:  Antoni Castells
Journal:  Gastroenterology       Date:  2008-11-08       Impact factor: 22.682

2.  The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome.

Authors:  Margaret O'Malley; Lisa LaGuardia; Matthew F Kalady; Joseph Parambil; Brandie Heald; Charis Eng; James Church; Carol A Burke
Journal:  Dis Colon Rectum       Date:  2012-08       Impact factor: 4.585

Review 3.  Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Authors:  Jeremy R Jass
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

4.  Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.

Authors:  Doua Bakry; Melyssa Aronson; Carol Durno; Hala Rimawi; Roula Farah; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Shay Ben-Shachar; Matthew Mistry; Shlomi Constantini; Rina Dvir; Ibrahim Qaddoumi; Steven Gallinger; Jordan Lerner-Ellis; Aaron Pollett; Derek Stephens; Steve Kelies; Elizabeth Chao; David Malkin; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  Eur J Cancer       Date:  2014-01-15       Impact factor: 9.162

5.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

6.  A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.

Authors:  Min-Han Tan; Jessica Mester; Charissa Peterson; Yiran Yang; Jin-Lian Chen; Lisa A Rybicki; Kresimira Milas; Holly Pederson; Berna Remzi; Mohammed S Orloff; Charis Eng
Journal:  Am J Hum Genet       Date:  2010-12-30       Impact factor: 11.025

Review 7.  Prophylactic colectomy: Rationale, indications, and approach.

Authors:  Matthew F Kalady; James M Church
Journal:  J Surg Oncol       Date:  2014-11-21       Impact factor: 3.454

8.  Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.

Authors:  Julian R Sampson; Sunil Dolwani; Sian Jones; Diana Eccles; Anthony Ellis; D Gareth Evans; Ian Frayling; Sheila Jordan; Eamonn R Maher; Tony Mak; Julie Maynard; Francesca Pigatto; Joan Shaw; Jeremy P Cheadle
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

9.  Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers.

Authors:  Waltraut Friedl; Siegfried Uhlhaas; Karsten Schulmann; Manfred Stolte; Steffan Loff; Walter Back; Elisabeth Mangold; Martin Stern; Hanns-Peter Knaebel; Christian Sutter; Ruthild G Weber; Steffen Pistorius; Bettina Burger; Peter Propping
Journal:  Hum Genet       Date:  2002-06-13       Impact factor: 4.132

10.  Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1.

Authors:  Emma Jaeger; Simon Leedham; Annabelle Lewis; Stefania Segditsas; Martin Becker; Pedro Rodenas Cuadrado; Hayley Davis; Kulvinder Kaur; Karl Heinimann; Kimberley Howarth; James East; Jenny Taylor; Huw Thomas; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

View more
  4 in total

1.  Intestinal bacterium-derived cyp27a1 prevents colon cancer cell apoptosis.

Authors:  Yan-Chao Ji; Chang Liu; Xia Zhang; Cheng-Sen Zhang; Dong Wang; Yan Zhang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

2.  Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.

Authors:  Maria C Katapodi; Valeria Viassolo; Maria Caiata-Zufferey; Christos Nikolaidis; Nicole Buerki; Karl Heinimann; Viola Heinzelmann-Schwarz; Olivia Pagani; Pierre O Chappuis; Rosmarie Bührer-Landolt; Rossella Graffeo; Henrik Csaba Horváth; Christian Kurzeder; Manuela Rabaglio; Michael Scharfe; Corinne Urech; Tobias E Erlanger; Nicole Probst-Hensch
Journal:  JMIR Res Protoc       Date:  2017-09-20

3.  Identification of Kininogen 1 as a Serum Protein Marker of Colorectal Adenoma in Patients with a Family History of Colorectal Cancer.

Authors:  Jiekai Yu; Yanqin Huang; Chen Lin; Xiaofen Li; Xuefeng Fang; Chenhan Zhong; Ying Yuan; Shu Zheng
Journal:  J Cancer       Date:  2018-03-08       Impact factor: 4.207

Review 4.  Recent advances in understanding Lynch syndrome.

Authors:  Sherief Shawki; Matthew F Kalady
Journal:  F1000Res       Date:  2016-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.